Share

    


In This Section

Companies A-Z

Search for Assistance Programs

PharmaEssentia

PharmaEssentia is working to redefine the potential of proven therapies to enhance the health and quality of life for patients living with hematologic diseases. Powered by world-class expertise and grounded in pioneering science, they are developing novel treatment solutions, beginning with therapies for myeloproliferative neoplasms.

For more information about their patient assistance program, visit their website.

Oncology-related products: BESREMi® (ropeginterferon alfa-2b-njft) subcutaneous injection

PharmaEssentia SOURCE™

PharmaEssentia offers BESREMi at no cost to eligible individuals, including those without insurance.

Patients may be eligible if they meet these requirements:

  • Not having prescription drug coverage, or your insurance does not cover BESREMi
  • Residing in the United States or a US territory
  • Having a valid prescription from a US physician for BESREMi
  • Meeting financial eligibility criteria 

Copay and Coinsurance Assistance Program

Eligible patients can receive BESREMi for as little as $0 per month.* This program covers copay, coinsurance, or deductible expenses for those who qualify.

A patient may be eligible if they meet requirements, such as:

  • Having commercial (private) insurance that covers BESREMi
  • Residing in the United States or a US territory
  • Having a valid prescription from a US physician for BESREMi

Enroll patients directly into the BESREMi Copay Program at www.besremicopay.com

For any questions or concerns, visit their website or call one of the dedicated PharmaEssentia SOURCE Case Managers at 800-700-5053 between 8:00 AM and 8:00 PM ET, Monday through Friday.

*Restrictions apply and are subject to change. Not available to patients with prescription insurance plans through any federal or state healthcare programs, including but not limited to Medicare, Medicaid, TRICARE, and Veterans Health Administration. This offer is not valid for cash-paying patients, where BESREMi is not covered by the patient’s commercial insurance, or where the plan reimburses patients for the entire cost of BESREMi.